Pazgier M - Search Results

1

Structure-function Analyses Reveal Key Molecular Determinants of HIV-1 CRF01_AE Resistance to the Entry Inhibitor Temsavir.

Prévost J, Chen Y, Zhou F, Tolbert WD, Gasser R, Medjahed H, Gottumukkala S, Hessell AJ, Rao VB, Pozharski E, Huang RK, Matthies D, Finzi A, Pazgier M. Prévost J, et al. Among authors: pazgier m. bioRxiv [Preprint]. 2023 Apr 17:2023.04.17.537181. doi: 10.1101/2023.04.17.537181. bioRxiv. 2023. PMID: 37131729 Free PMC article. Updated. Preprint.

2

Expression and purification of recombinant human alpha-defensins in Escherichia coli.

Pazgier M, Lubkowski J. Pazgier M, et al. Protein Expr Purif. 2006 Sep;49(1):1-8. doi: 10.1016/j.pep.2006.05.004. Epub 2006 May 20. Protein Expr Purif. 2006. PMID: 16839776

3

A left-handed solution to peptide inhibition of the p53-MDM2 interaction.

Liu M, Pazgier M, Li C, Yuan W, Li C, Lu W. Liu M, et al. Among authors: pazgier m. Angew Chem Int Ed Engl. 2010 May 10;49(21):3649-52. doi: 10.1002/anie.201000329. Angew Chem Int Ed Engl. 2010. PMID: 20449836 Free PMC article.

4

The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability.

Rajabi M, de Leeuw E, Pazgier M, Li J, Lubkowski J, Lu W. Rajabi M, et al. Among authors: pazgier m. J Biol Chem. 2008 Aug 1;283(31):21509-18. doi: 10.1074/jbc.M801851200. Epub 2008 May 22. J Biol Chem. 2008. PMID: 18499668 Free PMC article.

5

Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.

Li C, Pazgier M, Li C, Yuan W, Liu M, Wei G, Lu WY, Lu W. Li C, et al. Among authors: pazgier m. J Mol Biol. 2010 Apr 30;398(2):200-13. doi: 10.1016/j.jmb.2010.03.005. Epub 2010 Mar 10. J Mol Biol. 2010. PMID: 20226197 Free PMC article.

6

Studies of the biological properties of human beta-defensin 1.

Pazgier M, Prahl A, Hoover DM, Lubkowski J. Pazgier M, et al. J Biol Chem. 2007 Jan 19;282(3):1819-29. doi: 10.1074/jbc.M607210200. Epub 2006 Oct 27. J Biol Chem. 2007. PMID: 17071614 Free article.

7

Apamin as a template for structure-based rational design of potent peptide activators of p53.

Li C, Pazgier M, Liu M, Lu WY, Lu W. Li C, et al. Among authors: pazgier m. Angew Chem Int Ed Engl. 2009;48(46):8712-5. doi: 10.1002/anie.200904550. Angew Chem Int Ed Engl. 2009. PMID: 19827079 Free PMC article.

8

Structure of the isoaspartyl peptidase with L-asparaginase activity from Escherichia coli.

Prahl A, Pazgier M, Hejazi M, Lockau W, Lubkowski J. Prahl A, et al. Among authors: pazgier m. Acta Crystallogr D Biol Crystallogr. 2004 Jun;60(Pt 6):1173-6. doi: 10.1107/S0907444904003403. Epub 2004 May 21. Acta Crystallogr D Biol Crystallogr. 2004. PMID: 15159592

9

Through the looking glass, mechanistic insights from enantiomeric human defensins.

Wei G, de Leeuw E, Pazgier M, Yuan W, Zou G, Wang J, Ericksen B, Lu WY, Lehrer RI, Lu W. Wei G, et al. Among authors: pazgier m. J Biol Chem. 2009 Oct 16;284(42):29180-92. doi: 10.1074/jbc.M109.018085. Epub 2009 Jul 29. J Biol Chem. 2009. PMID: 19640840 Free PMC article.

10

Human defensins: synthesis and structural properties.

Pazgier M, Li X, Lu W, Lubkowski J. Pazgier M, et al. Curr Pharm Des. 2007;13(30):3096-118. doi: 10.2174/138161207782110381. Curr Pharm Des. 2007. PMID: 17979752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page